ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-476
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Human Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-476
Report
July 2025
Pages:196
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
Sanofi
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
Zhongke Biopharm
Zhuoyi Biological

Human Vaccine Market Size

In 2024, the global market size of Human Vaccine was estimated to be worth US$ 34990 million and is forecast to reach approximately US$ 47870 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.

Human Vaccine Market

Human Vaccine Market

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.
East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.
In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccine.
The Human Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Human Vaccine Market Report

Report Metric Details
Report Name Human Vaccine Market
CAGR 4.6%
Segment by Type
  • Varicella
  • Influenza
  • Polio
  • Hepatitis A
  • Rabies
  • BCG
  • Hepatitis B
  • Pertussis, Diphtheria, Tetanus
  • Pneumococcal
  • Rota vaccine
Segment by Application
  • Adults
  • Children
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CNBG, Changsheng Life, Zhifei, ChengDa Bio, Kangtai, SINOVAC BIOTECH, Hissen, Walvax Biotechnology, GSK, SANOFI, Rong An, NuoCheng Bio, Hualan Bio, Tiantan biological, Changchun Baike, Adimmune, Zhongyianke Biotech, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Indian Immunologicals, KANGH, Henan Grand Biopharma, ZhongKe Biopharm, Zhuoyi Biological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Human Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Human Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Human Vaccine Market?

Ans: Global top three manufacturers hold a share about 65%.

What is the Human Vaccine Market share by type?

Ans: In terms of product, Hepatitis B is the largest segment, with a share nearly 15%.

Who are the main players in the Human Vaccine Market report?

Ans: The main players in the Human Vaccine Market are CNBG, Changsheng Life, Zhifei, ChengDa Bio, Kangtai, SINOVAC BIOTECH, Hissen, Walvax Biotechnology, GSK, SANOFI, Rong An, NuoCheng Bio, Hualan Bio, Tiantan biological, Changchun Baike, Adimmune, Zhongyianke Biotech, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Indian Immunologicals, KANGH, Henan Grand Biopharma, ZhongKe Biopharm, Zhuoyi Biological

What are the Application segmentation covered in the Human Vaccine Market report?

Ans: The Applications covered in the Human Vaccine Market report are Adults, Children

What are the Type segmentation covered in the Human Vaccine Market report?

Ans: The Types covered in the Human Vaccine Market report are Varicella, Influenza, Polio, Hepatitis A, Rabies, BCG, Hepatitis B, Pertussis, Diphtheria, Tetanus, Pneumococcal, Rota vaccine

1 Study Coverage
1.1 Human Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Human Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.3 Market by Application
1.3.1 Global Human Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Vaccine Market Size Estimates and Forecasts
2.1.1 Global Human Vaccine Revenue 2020-2031
2.1.2 Global Human Vaccine Sales 2020-2031
2.2 Human Vaccine Market Size by Region: 2024 Versus 2031
2.3 Human Vaccine Sales by Region (2020-2031)
2.3.1 Global Human Vaccine Sales by Region: 2020-2025
2.3.2 Global Human Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global Human Vaccine Sales Market Share by Region (2020-2031)
2.4 Human Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Human Vaccine Revenue by Region: 2020-2025
2.4.2 Global Human Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global Human Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Human Vaccine Sales by Type (2020-2031)
3.1.1.1 Global Human Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global Human Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global Human Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global Human Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global Human Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 Human Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Human Vaccine Sales by Application (2020-2031)
3.2.1.1 Global Human Vaccine Sales Volume by Application (2020-2031)
3.2.1.2 Global Human Vaccine Sales Market Share by Application (2020-2031)
3.2.2 Global Human Vaccine Revenue by Application (2020-2031)
3.2.2.1 Global Human Vaccine Revenue by Application (2020-2031)
3.2.2.2 Global Human Vaccine Revenue Market Share by Application (2020-2031)
3.2.3 Human Vaccine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Varicella of Human Vaccine Revenue Market Share by Application
3.3.2 Influenza of Human Vaccine Revenue Market Share by Application
3.3.3 Polio of Human Vaccine Revenue Market Share by Application
3.3.4 Hepatitis A of Human Vaccine Revenue Market Share by Application
3.3.5 Rabies of Human Vaccine Revenue Market Share by Application
3.3.6 BCG of Human Vaccine Revenue Market Share by Application
3.3.7 Hepatitis B of Human Vaccine Revenue Market Share by Application
3.3.8 Pertussis, Diphtheria, Tetanus of Human Vaccine Revenue Market Share by Application
3.3.9 Pneumococcal of Human Vaccine Revenue Market Share by Application
4 Global Human Vaccine by Manufacturers
4.1 Global Top Human Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global Human Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global Human Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Human Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global Human Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global Human Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global Human Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Human Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Human Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Human Vaccine Manufacturing Base Distribution, Product Type
4.5.1 Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Human Vaccine Market
4.5.3 Manufacturers Human Vaccine Product Type and Application
4.5.4 Varicella Market Sales of Human Vaccine by Manufacturer
4.5.5 Influenza Market Sales of Human Vaccine by Manufacturer
4.5.6 Polio Market Sales of Human Vaccine by Manufacturer
4.5.7 Hepatitis A Market Sales of Human Vaccine by Manufacturer
4.5.8 Rabies Market Sales of Human Vaccine by Manufacturer
4.5.9 BCG Market Sales of Human Vaccine by Manufacturer
4.5.10 Hepatitis B Market Sales of Human Vaccine by Manufacturer
4.5.11 Pertussis, Diphtheria, Tetanus Market Sales of Human Vaccine by Manufacturer
4.5.12 Pneumococcal Market Sales of Human Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 CNBG
5.1.1 CNBG Company Information
5.1.2 CNBG Description, Business Overview
5.1.3 CNBG Human Vaccine Products Offered
5.1.4 CNBG Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 CNBG Human Vaccine Sales by Product in 2024
5.1.6 CNBG Human Vaccine Sales by Application in 2024
5.1.7 CNBG Human Vaccine Sales by Geographic Area in 2024
5.1.8 CNBG Recent Developments
5.2 Changsheng Life
5.2.1 Changsheng Life Company Information
5.2.2 Changsheng Life Description, Business Overview
5.2.3 Changsheng Life Human Vaccine Products Offered
5.2.4 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Changsheng Life Human Vaccine Sales by Product in 2024
5.2.6 Changsheng Life Human Vaccine Sales by Application in 2024
5.2.7 Changsheng Life Human Vaccine Sales by Geographic Area in 2024
5.2.8 Changsheng Life Recent Developments
5.3 Zhifei
5.3.1 Zhifei Company Information
5.3.2 Zhifei Description, Business Overview
5.3.3 Zhifei Human Vaccine Products Offered
5.3.4 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Zhifei Human Vaccine Sales by Product in 2024
5.3.6 Zhifei Human Vaccine Sales by Application in 2024
5.3.7 Zhifei Human Vaccine Sales by Geographic Area in 2024
5.3.8 Zhifei Recent Developments
5.4 ChengDa Bio
5.4.1 ChengDa Bio Company Information
5.4.2 ChengDa Bio Description, Business Overview
5.4.3 ChengDa Bio Human Vaccine Products Offered
5.4.4 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 ChengDa Bio Human Vaccine Sales by Product in 2024
5.4.6 ChengDa Bio Human Vaccine Sales by Application in 2024
5.4.7 ChengDa Bio Human Vaccine Sales by Geographic Area in 2024
5.4.8 ChengDa Bio Recent Developments
5.5 Kangtai
5.5.1 Kangtai Company Information
5.5.2 Kangtai Description, Business Overview
5.5.3 Kangtai Human Vaccine Products Offered
5.5.4 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Kangtai Human Vaccine Sales by Product in 2024
5.5.6 Kangtai Human Vaccine Sales by Application in 2024
5.5.7 Kangtai Human Vaccine Sales by Geographic Area in 2024
5.5.8 Kangtai Recent Developments
5.6 SINOVAC BIOTECH
5.6.1 SINOVAC BIOTECH Company Information
5.6.2 SINOVAC BIOTECH Description, Business Overview
5.6.3 SINOVAC BIOTECH Human Vaccine Products Offered
5.6.4 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 SINOVAC BIOTECH Human Vaccine Sales by Product in 2024
5.6.6 SINOVAC BIOTECH Human Vaccine Sales by Application in 2024
5.6.7 SINOVAC BIOTECH Human Vaccine Sales by Geographic Area in 2024
5.6.8 SINOVAC BIOTECH Recent Developments
5.7 Hissen
5.7.1 Hissen Company Information
5.7.2 Hissen Description, Business Overview
5.7.3 Hissen Human Vaccine Products Offered
5.7.4 Hissen Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Hissen Human Vaccine Sales by Product in 2024
5.7.6 Hissen Human Vaccine Sales by Application in 2024
5.7.7 Hissen Human Vaccine Sales by Geographic Area in 2024
5.7.8 Hissen Recent Developments
5.8 Walvax Biotechnology
5.8.1 Walvax Biotechnology Company Information
5.8.2 Walvax Biotechnology Description, Business Overview
5.8.3 Walvax Biotechnology Human Vaccine Products Offered
5.8.4 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Walvax Biotechnology Human Vaccine Sales by Product in 2024
5.8.6 Walvax Biotechnology Human Vaccine Sales by Application in 2024
5.8.7 Walvax Biotechnology Human Vaccine Sales by Geographic Area in 2024
5.8.8 Walvax Biotechnology Recent Developments
5.9 GSK
5.9.1 GSK Company Information
5.9.2 GSK Description, Business Overview
5.9.3 GSK Human Vaccine Products Offered
5.9.4 GSK Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.9.5 GSK Human Vaccine Sales by Product in 2024
5.9.6 GSK Human Vaccine Sales by Application in 2024
5.9.7 GSK Human Vaccine Sales by Geographic Area in 2024
5.9.8 GSK Recent Developments
5.10 SANOFI
5.10.1 SANOFI Company Information
5.10.2 SANOFI Description, Business Overview
5.10.3 SANOFI Human Vaccine Products Offered
5.10.4 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.10.5 SANOFI Human Vaccine Sales by Product in 2024
5.10.6 SANOFI Human Vaccine Sales by Application in 2024
5.10.7 SANOFI Human Vaccine Sales by Geographic Area in 2024
5.10.8 SANOFI Recent Developments
5.11 Rong An
5.11.1 Rong An Company Information
5.11.2 Rong An Description, Business Overview
5.11.3 Rong An Human Vaccine Products Offered
5.11.4 Rong An Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Rong An Human Vaccine Sales by Product in 2024
5.11.6 Rong An Human Vaccine Sales by Application in 2024
5.11.7 Rong An Human Vaccine Sales by Geographic Area in 2024
5.11.8 Rong An Recent Developments
5.12 NuoCheng Bio
5.12.1 NuoCheng Bio Company Information
5.12.2 NuoCheng Bio Description, Business Overview
5.12.3 NuoCheng Bio Human Vaccine Products Offered
5.12.4 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.12.5 NuoCheng Bio Human Vaccine Sales by Product in 2024
5.12.6 NuoCheng Bio Human Vaccine Sales by Application in 2024
5.12.7 NuoCheng Bio Human Vaccine Sales by Geographic Area in 2024
5.12.8 NuoCheng Bio Recent Developments
5.13 Hualan Bio
5.13.1 Hualan Bio Company Information
5.13.2 Hualan Bio Description, Business Overview
5.13.3 Hualan Bio Human Vaccine Products Offered
5.13.4 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Hualan Bio Human Vaccine Sales by Product in 2024
5.13.6 Hualan Bio Human Vaccine Sales by Application in 2024
5.13.7 Hualan Bio Human Vaccine Sales by Geographic Area in 2024
5.13.8 Hualan Bio Recent Developments
5.14 Tiantan biological
5.14.1 Tiantan biological Company Information
5.14.2 Tiantan biological Description, Business Overview
5.14.3 Tiantan biological Human Vaccine Products Offered
5.14.4 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Tiantan biological Human Vaccine Sales by Product in 2024
5.14.6 Tiantan biological Human Vaccine Sales by Application in 2024
5.14.7 Tiantan biological Human Vaccine Sales by Geographic Area in 2024
5.14.8 Tiantan biological Recent Developments
5.15 Changchun Baike
5.15.1 Changchun Baike Company Information
5.15.2 Changchun Baike Description, Business Overview
5.15.3 Changchun Baike Human Vaccine Products Offered
5.15.4 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Changchun Baike Human Vaccine Sales by Product in 2024
5.15.6 Changchun Baike Human Vaccine Sales by Application in 2024
5.15.7 Changchun Baike Human Vaccine Sales by Geographic Area in 2024
5.15.8 Changchun Baike Recent Developments
5.16 Adimmune
5.16.1 Adimmune Company Information
5.16.2 Adimmune Description, Business Overview
5.16.3 Adimmune Human Vaccine Products Offered
5.16.4 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Adimmune Human Vaccine Sales by Product in 2024
5.16.6 Adimmune Human Vaccine Sales by Application in 2024
5.16.7 Adimmune Human Vaccine Sales by Geographic Area in 2024
5.16.8 Adimmune Recent Developments
5.17 Zhongyianke Biotech
5.17.1 Zhongyianke Biotech Company Information
5.17.2 Zhongyianke Biotech Description, Business Overview
5.17.3 Zhongyianke Biotech Human Vaccine Products Offered
5.17.4 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.17.5 Zhongyianke Biotech Human Vaccine Sales by Product in 2024
5.17.6 Zhongyianke Biotech Human Vaccine Sales by Application in 2024
5.17.7 Zhongyianke Biotech Human Vaccine Sales by Geographic Area in 2024
5.17.8 Zhongyianke Biotech Recent Developments
5.18 Bharat Biotech
5.18.1 Bharat Biotech Company Information
5.18.2 Bharat Biotech Description, Business Overview
5.18.3 Bharat Biotech Human Vaccine Products Offered
5.18.4 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Bharat Biotech Human Vaccine Sales by Product in 2024
5.18.6 Bharat Biotech Human Vaccine Sales by Application in 2024
5.18.7 Bharat Biotech Human Vaccine Sales by Geographic Area in 2024
5.18.8 Bharat Biotech Recent Developments
5.19 Bavarian Nordic
5.19.1 Bavarian Nordic Company Information
5.19.2 Bavarian Nordic Description, Business Overview
5.19.3 Bavarian Nordic Human Vaccine Products Offered
5.19.4 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.19.5 Bavarian Nordic Human Vaccine Sales by Product in 2024
5.19.6 Bavarian Nordic Human Vaccine Sales by Application in 2024
5.19.7 Bavarian Nordic Human Vaccine Sales by Geographic Area in 2024
5.19.8 Bavarian Nordic Recent Developments
5.20 Sanofi-Pasteur
5.20.1 Sanofi-Pasteur Company Information
5.20.2 Sanofi-Pasteur Description, Business Overview
5.20.3 Sanofi-Pasteur Human Vaccine Products Offered
5.20.4 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.20.5 Sanofi-Pasteur Human Vaccine Sales by Product in 2024
5.20.6 Sanofi-Pasteur Human Vaccine Sales by Application in 2024
5.20.7 Sanofi-Pasteur Human Vaccine Sales by Geographic Area in 2024
5.20.8 Sanofi-Pasteur Recent Developments
5.21 Indian Immunologicals
5.21.1 Indian Immunologicals Company Information
5.21.2 Indian Immunologicals Description, Business Overview
5.21.3 Indian Immunologicals Human Vaccine Products Offered
5.21.4 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.21.5 Indian Immunologicals Human Vaccine Sales by Product in 2024
5.21.6 Indian Immunologicals Human Vaccine Sales by Application in 2024
5.21.7 Indian Immunologicals Human Vaccine Sales by Geographic Area in 2024
5.21.8 Indian Immunologicals Recent Developments
5.22 KANGH
5.22.1 KANGH Company Information
5.22.2 KANGH Description, Business Overview
5.22.3 KANGH Human Vaccine Products Offered
5.22.4 KANGH Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.22.5 KANGH Human Vaccine Sales by Product in 2024
5.22.6 KANGH Human Vaccine Sales by Application in 2024
5.22.7 KANGH Human Vaccine Sales by Geographic Area in 2024
5.22.8 KANGH Recent Developments
5.23 Henan Grand Biopharma
5.23.1 Henan Grand Biopharma Company Information
5.23.2 Henan Grand Biopharma Description, Business Overview
5.23.3 Henan Grand Biopharma Human Vaccine Products Offered
5.23.4 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.23.5 Henan Grand Biopharma Human Vaccine Sales by Product in 2024
5.23.6 Henan Grand Biopharma Human Vaccine Sales by Application in 2024
5.23.7 Henan Grand Biopharma Human Vaccine Sales by Geographic Area in 2024
5.23.8 Henan Grand Biopharma Recent Developments
5.24 ZhongKe Biopharm
5.24.1 ZhongKe Biopharm Company Information
5.24.2 ZhongKe Biopharm Description, Business Overview
5.24.3 ZhongKe Biopharm Human Vaccine Products Offered
5.24.4 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.24.5 ZhongKe Biopharm Human Vaccine Sales by Product in 2024
5.24.6 ZhongKe Biopharm Human Vaccine Sales by Application in 2024
5.24.7 ZhongKe Biopharm Human Vaccine Sales by Geographic Area in 2024
5.24.8 ZhongKe Biopharm Recent Developments
5.25 Zhuoyi Biological
5.25.1 Zhuoyi Biological Company Information
5.25.2 Zhuoyi Biological Description, Business Overview
5.25.3 Zhuoyi Biological Human Vaccine Products Offered
5.25.4 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.25.5 Zhuoyi Biological Human Vaccine Sales by Product in 2024
5.25.6 Zhuoyi Biological Human Vaccine Sales by Application in 2024
5.25.7 Zhuoyi Biological Human Vaccine Sales by Geographic Area in 2024
5.25.8 Zhuoyi Biological Recent Developments
6 North America
6.1 North America Human Vaccine Market Size YoY Growth 2020-2031
6.2 North America Human Vaccine Market Facts & Figures by Country
6.2.1 North America Human Vaccine Sales by Country (2020-2031)
6.2.2 North America Human Vaccine Revenue by Country (2020-2031)
6.3 North America Human Vaccine Sales by Type (2020-2025)
6.4 North America Human Vaccine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Human Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Human Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific Human Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Human Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific Human Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific Human Vaccine Sales by Application (2020-2025)
8 Europe
8.1 Europe Human Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Human Vaccine Market Facts & Figures by Country
8.2.1 Europe Human Vaccine Sales by Country (2020-2031)
8.2.2 Europe Human Vaccine Revenue by Country (2020-2031)
8.3 Europe Human Vaccine Sales by Type (2020-2025)
8.4 Europe Human Vaccine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Human Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Human Vaccine Market Facts & Figures by Country
9.2.1 Latin America Human Vaccine Sales by Country (2020-2031)
9.2.2 Latin America Human Vaccine Revenue by Country (2020-2031)
9.3 Latin America Human Vaccine Sales by Type (2020-2025)
9.4 Latin America Human Vaccine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Human Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Human Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa Human Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Human Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa Human Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa Human Vaccine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Human Vaccine Supply Chain Analysis
11.2 Human Vaccine Key Raw Materials and Upstream Suppliers
11.3 Human Vaccine Clients Analysis
11.4 Human Vaccine Sales Channel and Sales Model Analysis
11.4.1 Human Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Human Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Human Vaccine Distributors
12 Human Vaccine Market Dynamics
12.1 Human Vaccine Industry Trends
12.2 Human Vaccine Market Drivers
12.3 Human Vaccine Market Challenges
12.4 Human Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
Sanofi
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
Zhongke Biopharm
Zhuoyi Biological
List of Tables
 Table 1. Global Human Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Human Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Human Vaccine Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Human Vaccine Sales by Region (2020-2025) & (M Doses)
 Table 5. Global Human Vaccine Sales Forecast by Region (2026-2031) & (M Doses)
 Table 6. Global Human Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Human Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Human Vaccine Sales Volume by Type (2020-2025) & (M Doses)
 Table 9. Global Human Vaccine Sales Volume by Type (2026-2031) & (M Doses)
 Table 10. Global Human Vaccine Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Human Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Human Vaccine Sales Volume by Application (2020-2025) & (M Doses)
 Table 13. Global Human Vaccine Sales Volume by Application (2026-2031) & (M Doses)
 Table 14. Global Human Vaccine Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Human Vaccine Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Human Vaccine Sales by Manufacturer (2020-2025) & (M Doses)
 Table 17. Global Human Vaccine Sales Share by Manufacturer (2020-2025)
 Table 18. Human Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Human Vaccine Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Human Vaccine Price (2020-2025) & (USD/Dose)
 Table 21. Ranking of Global Top Human Vaccine Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Human Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccine as of 2024)
 Table 24. Human Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Human Vaccine Market
 Table 26. Manufacturers Human Vaccine Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. CNBG Company Information
 Table 29. CNBG Description and Business Overview
 Table 30. CNBG Human Vaccine Product
 Table 31. CNBG Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 32. CNBG Sales Proportion of Human Vaccine by Product in 2024
 Table 33. CNBG Sales Proportion of Human Vaccine by Application in 2024
 Table 34. CNBG Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 35. CNBG Recent Developments
 Table 36. Changsheng Life Company Information
 Table 37. Changsheng Life Description and Business Overview
 Table 38. Changsheng Life Human Vaccine Product
 Table 39. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 40. Changsheng Life Sales Proportion of Human Vaccine by Product in 2024
 Table 41. Changsheng Life Sales Proportion of Human Vaccine by Application in 2024
 Table 42. Changsheng Life Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 43. Changsheng Life Recent Developments
 Table 44. Zhifei Company Information
 Table 45. Zhifei Description and Business Overview
 Table 46. Zhifei Human Vaccine Product
 Table 47. Zhifei Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 48. Zhifei Sales Proportion of Human Vaccine by Product in 2024
 Table 49. Zhifei Sales Proportion of Human Vaccine by Application in 2024
 Table 50. Zhifei Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 51. Zhifei Recent Developments
 Table 52. ChengDa Bio Company Information
 Table 53. ChengDa Bio Description and Business Overview
 Table 54. ChengDa Bio Human Vaccine Product
 Table 55. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 56. ChengDa Bio Sales Proportion of Human Vaccine by Product in 2024
 Table 57. ChengDa Bio Sales Proportion of Human Vaccine by Application in 2024
 Table 58. ChengDa Bio Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 59. ChengDa Bio Recent Developments
 Table 60. Kangtai Company Information
 Table 61. Kangtai Description and Business Overview
 Table 62. Kangtai Human Vaccine Product
 Table 63. Kangtai Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 64. Kangtai Sales Proportion of Human Vaccine by Product in 2024
 Table 65. Kangtai Sales Proportion of Human Vaccine by Application in 2024
 Table 66. Kangtai Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 67. Kangtai Recent Developments
 Table 68. SINOVAC BIOTECH Company Information
 Table 69. SINOVAC BIOTECH Description and Business Overview
 Table 70. SINOVAC BIOTECH Human Vaccine Product
 Table 71. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 72. SINOVAC BIOTECH Sales Proportion of Human Vaccine by Product in 2024
 Table 73. SINOVAC BIOTECH Sales Proportion of Human Vaccine by Application in 2024
 Table 74. SINOVAC BIOTECH Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 75. SINOVAC BIOTECH Recent Developments
 Table 76. Hissen Company Information
 Table 77. Hissen Description and Business Overview
 Table 78. Hissen Human Vaccine Product
 Table 79. Hissen Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 80. Hissen Sales Proportion of Human Vaccine by Product in 2024
 Table 81. Hissen Sales Proportion of Human Vaccine by Application in 2024
 Table 82. Hissen Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 83. Hissen Recent Developments
 Table 84. Walvax Biotechnology Company Information
 Table 85. Walvax Biotechnology Description and Business Overview
 Table 86. Walvax Biotechnology Human Vaccine Product
 Table 87. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. Walvax Biotechnology Sales Proportion of Human Vaccine by Product in 2024
 Table 89. Walvax Biotechnology Sales Proportion of Human Vaccine by Application in 2024
 Table 90. Walvax Biotechnology Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 91. Walvax Biotechnology Recent Developments
 Table 92. GSK Company Information
 Table 93. GSK Description and Business Overview
 Table 94. GSK Human Vaccine Product
 Table 95. GSK Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 96. GSK Sales Proportion of Human Vaccine by Product in 2024
 Table 97. GSK Sales Proportion of Human Vaccine by Application in 2024
 Table 98. GSK Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 99. GSK Recent Developments
 Table 100. SANOFI Company Information
 Table 101. SANOFI Description and Business Overview
 Table 102. SANOFI Human Vaccine Product
 Table 103. SANOFI Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 104. SANOFI Sales Proportion of Human Vaccine by Product in 2024
 Table 105. SANOFI Sales Proportion of Human Vaccine by Application in 2024
 Table 106. SANOFI Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 107. SANOFI Recent Developments
 Table 108. Rong An Company Information
 Table 109. Rong An Description and Business Overview
 Table 110. Rong An Human Vaccine Product
 Table 111. Rong An Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 112. Rong An Sales Proportion of Human Vaccine by Product in 2024
 Table 113. Rong An Sales Proportion of Human Vaccine by Application in 2024
 Table 114. Rong An Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 115. Rong An Recent Developments
 Table 116. NuoCheng Bio Company Information
 Table 117. NuoCheng Bio Description and Business Overview
 Table 118. NuoCheng Bio Human Vaccine Product
 Table 119. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 120. NuoCheng Bio Sales Proportion of Human Vaccine by Product in 2024
 Table 121. NuoCheng Bio Sales Proportion of Human Vaccine by Application in 2024
 Table 122. NuoCheng Bio Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 123. NuoCheng Bio Recent Developments
 Table 124. Hualan Bio Company Information
 Table 125. Hualan Bio Description and Business Overview
 Table 126. Hualan Bio Human Vaccine Product
 Table 127. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 128. Hualan Bio Sales Proportion of Human Vaccine by Product in 2024
 Table 129. Hualan Bio Sales Proportion of Human Vaccine by Application in 2024
 Table 130. Hualan Bio Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 131. Hualan Bio Recent Developments
 Table 132. Tiantan biological Company Information
 Table 133. Tiantan biological Description and Business Overview
 Table 134. Tiantan biological Human Vaccine Product
 Table 135. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 136. Tiantan biological Sales Proportion of Human Vaccine by Product in 2024
 Table 137. Tiantan biological Sales Proportion of Human Vaccine by Application in 2024
 Table 138. Tiantan biological Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 139. Tiantan biological Recent Developments
 Table 140. Changchun Baike Company Information
 Table 141. Changchun Baike Description and Business Overview
 Table 142. Changchun Baike Human Vaccine Product
 Table 143. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 144. Changchun Baike Sales Proportion of Human Vaccine by Product in 2024
 Table 145. Changchun Baike Sales Proportion of Human Vaccine by Application in 2024
 Table 146. Changchun Baike Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 147. Changchun Baike Recent Developments
 Table 148. Adimmune Company Information
 Table 149. Adimmune Description and Business Overview
 Table 150. Adimmune Human Vaccine Product
 Table 151. Adimmune Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 152. Adimmune Sales Proportion of Human Vaccine by Product in 2024
 Table 153. Adimmune Sales Proportion of Human Vaccine by Application in 2024
 Table 154. Adimmune Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 155. Adimmune Recent Developments
 Table 156. Zhongyianke Biotech Company Information
 Table 157. Zhongyianke Biotech Description and Business Overview
 Table 158. Zhongyianke Biotech Human Vaccine Product
 Table 159. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 160. Zhongyianke Biotech Sales Proportion of Human Vaccine by Product in 2024
 Table 161. Zhongyianke Biotech Sales Proportion of Human Vaccine by Application in 2024
 Table 162. Zhongyianke Biotech Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 163. Zhongyianke Biotech Recent Developments
 Table 164. Bharat Biotech Company Information
 Table 165. Bharat Biotech Description and Business Overview
 Table 166. Bharat Biotech Human Vaccine Product
 Table 167. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 168. Bharat Biotech Sales Proportion of Human Vaccine by Product in 2024
 Table 169. Bharat Biotech Sales Proportion of Human Vaccine by Application in 2024
 Table 170. Bharat Biotech Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 171. Bharat Biotech Recent Developments
 Table 172. Bavarian Nordic Company Information
 Table 173. Bavarian Nordic Description and Business Overview
 Table 174. Bavarian Nordic Human Vaccine Product
 Table 175. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 176. Bavarian Nordic Sales Proportion of Human Vaccine by Product in 2024
 Table 177. Bavarian Nordic Sales Proportion of Human Vaccine by Application in 2024
 Table 178. Bavarian Nordic Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 179. Bavarian Nordic Recent Developments
 Table 180. Sanofi-Pasteur Company Information
 Table 181. Sanofi-Pasteur Description and Business Overview
 Table 182. Sanofi-Pasteur Human Vaccine Product
 Table 183. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 184. Sanofi-Pasteur Sales Proportion of Human Vaccine by Product in 2024
 Table 185. Sanofi-Pasteur Sales Proportion of Human Vaccine by Application in 2024
 Table 186. Sanofi-Pasteur Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 187. Sanofi-Pasteur Recent Developments
 Table 188. Indian Immunologicals Company Information
 Table 189. Indian Immunologicals Description and Business Overview
 Table 190. Indian Immunologicals Human Vaccine Product
 Table 191. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 192. Indian Immunologicals Sales Proportion of Human Vaccine by Product in 2024
 Table 193. Indian Immunologicals Sales Proportion of Human Vaccine by Application in 2024
 Table 194. Indian Immunologicals Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 195. Indian Immunologicals Recent Developments
 Table 196. KANGH Company Information
 Table 197. KANGH Description and Business Overview
 Table 198. KANGH Human Vaccine Product
 Table 199. KANGH Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 200. KANGH Sales Proportion of Human Vaccine by Product in 2024
 Table 201. KANGH Sales Proportion of Human Vaccine by Application in 2024
 Table 202. KANGH Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 203. KANGH Recent Developments
 Table 204. Henan Grand Biopharma Company Information
 Table 205. Henan Grand Biopharma Description and Business Overview
 Table 206. Henan Grand Biopharma Human Vaccine Product
 Table 207. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 208. Henan Grand Biopharma Sales Proportion of Human Vaccine by Product in 2024
 Table 209. Henan Grand Biopharma Sales Proportion of Human Vaccine by Application in 2024
 Table 210. Henan Grand Biopharma Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 211. Henan Grand Biopharma Recent Developments
 Table 212. ZhongKe Biopharm Company Information
 Table 213. ZhongKe Biopharm Description and Business Overview
 Table 214. ZhongKe Biopharm Human Vaccine Product
 Table 215. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 216. ZhongKe Biopharm Sales Proportion of Human Vaccine by Product in 2024
 Table 217. ZhongKe Biopharm Sales Proportion of Human Vaccine by Application in 2024
 Table 218. ZhongKe Biopharm Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 219. ZhongKe Biopharm Recent Developments
 Table 220. Zhuoyi Biological Company Information
 Table 221. Zhuoyi Biological Description and Business Overview
 Table 222. Zhuoyi Biological Human Vaccine Product
 Table 223. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 224. Zhuoyi Biological Sales Proportion of Human Vaccine by Product in 2024
 Table 225. Zhuoyi Biological Sales Proportion of Human Vaccine by Application in 2024
 Table 226. Zhuoyi Biological Sales Proportion of Human Vaccine by Geographic Area in 2024
 Table 227. Zhuoyi Biological Recent Developments
 Table 228. North America Human Vaccine Sales by Country (2020-2025) & (M Doses)
 Table 229. North America Human Vaccine Sales by Country (2026-2031) & (M Doses)
 Table 230. North America Human Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 231. North America Human Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 232. North America Human Vaccine Sales by Type (2020-2025) & (M Doses)
 Table 233. North America Human Vaccine Sales by Application (2020-2025) & (M Doses)
 Table 234. Asia-Pacific Human Vaccine Sales by Region (2020-2025) & (M Doses)
 Table 235. Asia-Pacific Human Vaccine Sales by Region (2026-2031) & (M Doses)
 Table 236. Asia-Pacific Human Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 237. Asia-Pacific Human Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 238. Asia-Pacific Human Vaccine Sales by Type (2020-2025) & (M Doses)
 Table 239. Asia-Pacific Human Vaccine Sales by Application (2020-2025) & (M Doses)
 Table 240. Europe Human Vaccine Sales by Country (2020-2025) & (M Doses)
 Table 241. Europe Human Vaccine Sales by Country (2026-2031) & (M Doses)
 Table 242. Europe Human Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 243. Europe Human Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 244. Europe Human Vaccine Sales by Type (2020-2025) & (M Doses)
 Table 245. Europe Human Vaccine Sales by Application (2020-2025) & (M Doses)
 Table 246. Latin America Human Vaccine Sales by Country (2020-2025) & (M Doses)
 Table 247. Latin America Human Vaccine Sales by Country (2026-2031) & (M Doses)
 Table 248. Latin America Human Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 249. Latin America Human Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 250. Latin America Human Vaccine Sales by Type (2020-2025) & (M Doses)
 Table 251. Latin America Human Vaccine Sales by Application (2020-2025) & (M Doses)
 Table 252. Middle East and Africa Human Vaccine Sales by Country (2020-2025) & (M Doses)
 Table 253. Middle East and Africa Human Vaccine Sales by Country (2026-2031) & (M Doses)
 Table 254. Middle East and Africa Human Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 255. Middle East and Africa Human Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 256. Middle East and Africa Human Vaccine Sales by Type (2020-2025) & (M Doses)
 Table 257. Middle East and Africa Human Vaccine Sales by Application (2020-2025) & (M Doses)
 Table 258. Human Vaccine Key Raw Materials, Industry Status and Trend
 Table 259. Human Vaccine Key Raw Materials and Upstream Suppliers
 Table 260. Human Vaccine Clients Status and Trend
 Table 261. Human Vaccine Typical Clients
 Table 262. Human Vaccine Distributors
 Table 263. Human Vaccine Market Trends
 Table 264. Human Vaccine Market Drivers
 Table 265. Human Vaccine Market Challenges
 Table 266. Human Vaccine Market Restraints
 Table 267. Research Programs/Design for This Report
 Table 268. Key Data Information from Secondary Sources
 Table 269. Key Data Information from Primary Sources
 Table 270. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Human Vaccine Product Picture
 Figure 2. Global Human Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Human Vaccine Sales Market Share by Type in 2024 & 2031
 Figure 4. Varicella Product Picture
 Figure 5. Influenza Product Picture
 Figure 6. Polio Product Picture
 Figure 7. Hepatitis A Product Picture
 Figure 8. Rabies Product Picture
 Figure 9. BCG Product Picture
 Figure 10. Hepatitis B Product Picture
 Figure 11. Pertussis, Diphtheria, Tetanus Product Picture
 Figure 12. Pneumococcal Product Picture
 Figure 13. Global Human Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 14. Global Human Vaccine Sales Market Share by Application in 2024 & 2031
 Figure 15. Adults
 Figure 16. Children
 Figure 17. Human Vaccine Report Years Considered
 Figure 18. Global Human Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Human Vaccine Market Size 2020-2031 (US$ Million)
 Figure 20. Global Human Vaccine Sales 2020-2031 (M Doses)
 Figure 21. Global Human Vaccine Sales Market Share Forecast by Region (2020-2031)
 Figure 22. Global Human Vaccine Revenue Market Share by Region (2020-2031)
 Figure 23. Global Human Vaccine Sales Market Share Forecast by Type (2020-2031)
 Figure 24. Global Human Vaccine Revenue Market Share Forecast by Type (2020-2031)
 Figure 25. Human Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Dose)
 Figure 26. Global Human Vaccine Sales Market Share Forecast by Application (2020-2031)
 Figure 27. Global Human Vaccine Revenue Market Share Forecast by Application (2020-2031)
 Figure 28. Human Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/Dose)
 Figure 29. Varicella of Human Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 30. Influenza of Human Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 31. Polio of Human Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 32. Hepatitis A of Human Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 33. Rabies of Human Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 34. BCG of Human Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 35. Hepatitis B of Human Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 36. Pertussis, Diphtheria, Tetanus of Human Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 37. Pneumococcal of Human Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 38. Global Human Vaccine Sales Share by Manufacturer in 2024
 Figure 39. Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 40. Varicella Market Sales Proportion by Manufacturer in 2024
 Figure 41. Influenza Market Sales Proportion by Manufacturer in 2024
 Figure 42. Polio Market Sales Proportion by Manufacturer in 2024
 Figure 43. Hepatitis A Market Sales Proportion by Manufacturer in 2024
 Figure 44. Rabies Market Sales Proportion by Manufacturer in 2024
 Figure 45. BCG Market Sales Proportion by Manufacturer in 2024
 Figure 46. Hepatitis B Market Sales Proportion by Manufacturer in 2024
 Figure 47. Pertussis, Diphtheria, Tetanus Market Sales Proportion by Manufacturer in 2024
 Figure 48. Pneumococcal Market Sales Proportion by Manufacturer in 2024
 Figure 49. North America Human Vaccine Revenue 2020-2031 (US$ Million)
 Figure 50. North America Human Vaccine Sales Market Share by Type (2020-2025)
 Figure 51. North America Human Vaccine Sales Market Share by Application (2020-2025)
 Figure 52. Asia-Pacific Human Vaccine Revenue 2020-2031 (US$ Million)
 Figure 53. Asia-Pacific Human Vaccine Sales Market Share by Region (2020-2031)
 Figure 54. Asia-Pacific Human Vaccine Revenue Market Share by Region (2020-2031)
 Figure 55. Asia-Pacific Human Vaccine Sales Market Share by Type (2020-2025)
 Figure 56. Asia-Pacific Human Vaccine Sales Market Share by Application (2020-2025)
 Figure 57. Europe Human Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 58. Europe Human Vaccine Sales Market Share by Country (2020-2031)
 Figure 59. Europe Human Vaccine Revenue Market Share by Country (2020-2031)
 Figure 60. Europe Human Vaccine Sales Market Share by Type (2020-2025)
 Figure 61. Europe Human Vaccine Sales Market Share by Application (2020-2025)
 Figure 62. Latin America Human Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 63. Latin America Human Vaccine Sales Market Share by Country (2020-2031)
 Figure 64. Latin America Human Vaccine Revenue Market Share by Country (2020-2025)
 Figure 65. Latin America Human Vaccine Sales Market Share by Type (2020-2025)
 Figure 66. Latin America Human Vaccine Sales Market Share by Application (2020-2025)
 Figure 67. Middle East and Africa Human Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 68. Middle East and Africa Human Vaccine Sales Market Share by Country (2020-2031)
 Figure 69. Middle East and Africa Human Vaccine Revenue Market Share by Country (2020-2031)
 Figure 70. Middle East and Africa Human Vaccine Sales Market Share by Type (2020-2025)
 Figure 71. Middle East and Africa Human Vaccine Sales Market Share by Application (2020-2025)
 Figure 72. Human Vaccine Supply Chain (Upstream and Downstream Market)
 Figure 73. Global Production Market Share of Human Vaccine Raw Materials by Region in 2024
 Figure 74. Human Vaccine Distribution Channels
 Figure 75. Global Human Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 76. Global Human Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 77. Bottom-up and Top-down Approaches for This Report
 Figure 78. Data Triangulation
 Figure 79. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Human Vaccination Market Research Report 2025
Global Travelers Vaccination Market Research Report 2025
Global Travelers Vaccines Market Research Report 2025
Vaccine Include COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dog Vaccines Market Insights Forecast to 2030
Global Cat Vaccines Market Insights Forecast to 2030
Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biological Vaccines Adjuvants Market Research Report 2025
Farm Animal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Biological Vaccines Market Research Report 2025
Global Biopharmaceutical and Vaccine Production Market Insights Forecast to 2030
Global Livestock Animal Vaccines Market Research Report 2024
Global Veterinary Vaccination Market Research Report 2025
Global Prophylactic Human Vaccine Market Research Report 2025
Global Nucleic Vaccine Market Insights Forecast to 2030
Animal Vaccine Adjuvant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Veterinary Vaccine Market
Global Animal Vaccines Market Insights Forecast to 2030
Veterinary Vaccine Adjuvants Market
Global Livestock Animal Vaccination Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions